Cutaneous Rhizopus infection at a central venous catheter site in a critically ill renal transplant patient

Zoel A. Quinez, John T. Speicher, Christian Sebat, Mark V Avdalovic

Research output: Contribution to journalArticle

Abstract

Invasive fungal infections are increasing in incidence, along with the use of immunosuppressive medications for the prevention of organ transplant rejection, graft versus host disease and treatment of auto-immune disorders. Additionally, the incidence of invasive fungal infections is increasing with the use of new antineoplastic therapies for malignancy, increasing incidence of diabetes mellitus, expanded use of broad-spectrum antimicrobial therapy and with an aging population with chronic medical problems such as chronic renal failure, chronic obstructive pulmonary disease and HIV. We present a case of primary cutaneous zygomycosis at the insertion site of a central venous catheter in a 45-year-old renal transplant patient admitted for acute pancreatitis. In the critical care setting, clinicians must retain a high index of suspicion for invasive fungal infections in immunocompromised individuals to ensure early diagnosis and provide aggressive medical and surgical intervention. Liposomal amphoterin B is the first line antimicrobial therapy, and reduction or discontinuation of immunosuppressive therapy should be considered. Currently there are no consensus opinions or recommendations for routine, scheduled replacement of central venous catheters to prevent infections, even in immunosuppressed patients.

Original languageEnglish (US)
Pages (from-to)83-86
Number of pages4
JournalHealthcare Infection
Volume17
Issue number3
DOIs
StatePublished - Sep 2012

Fingerprint

Rhizopus
Central Venous Catheters
Critical Illness
Transplants
Kidney
Skin
Infection
Immunosuppressive Agents
Incidence
Zygomycosis
HMGB1 Protein
Therapeutics
Immune System Diseases
Graft Rejection
Graft vs Host Disease
Critical Care
Pancreatitis
Antineoplastic Agents
Chronic Obstructive Pulmonary Disease
Chronic Kidney Failure

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Cutaneous Rhizopus infection at a central venous catheter site in a critically ill renal transplant patient. / Quinez, Zoel A.; Speicher, John T.; Sebat, Christian; Avdalovic, Mark V.

In: Healthcare Infection, Vol. 17, No. 3, 09.2012, p. 83-86.

Research output: Contribution to journalArticle

@article{1aa7c9bee15b47bba359fad5d5c43f74,
title = "Cutaneous Rhizopus infection at a central venous catheter site in a critically ill renal transplant patient",
abstract = "Invasive fungal infections are increasing in incidence, along with the use of immunosuppressive medications for the prevention of organ transplant rejection, graft versus host disease and treatment of auto-immune disorders. Additionally, the incidence of invasive fungal infections is increasing with the use of new antineoplastic therapies for malignancy, increasing incidence of diabetes mellitus, expanded use of broad-spectrum antimicrobial therapy and with an aging population with chronic medical problems such as chronic renal failure, chronic obstructive pulmonary disease and HIV. We present a case of primary cutaneous zygomycosis at the insertion site of a central venous catheter in a 45-year-old renal transplant patient admitted for acute pancreatitis. In the critical care setting, clinicians must retain a high index of suspicion for invasive fungal infections in immunocompromised individuals to ensure early diagnosis and provide aggressive medical and surgical intervention. Liposomal amphoterin B is the first line antimicrobial therapy, and reduction or discontinuation of immunosuppressive therapy should be considered. Currently there are no consensus opinions or recommendations for routine, scheduled replacement of central venous catheters to prevent infections, even in immunosuppressed patients.",
author = "Quinez, {Zoel A.} and Speicher, {John T.} and Christian Sebat and Avdalovic, {Mark V}",
year = "2012",
month = "9",
doi = "10.1071/HI12011",
language = "English (US)",
volume = "17",
pages = "83--86",
journal = "Infection, Disease and Health",
issn = "2468-0451",
publisher = "Australasian College for Infection Prevention and Control (ACIPC)",
number = "3",

}

TY - JOUR

T1 - Cutaneous Rhizopus infection at a central venous catheter site in a critically ill renal transplant patient

AU - Quinez, Zoel A.

AU - Speicher, John T.

AU - Sebat, Christian

AU - Avdalovic, Mark V

PY - 2012/9

Y1 - 2012/9

N2 - Invasive fungal infections are increasing in incidence, along with the use of immunosuppressive medications for the prevention of organ transplant rejection, graft versus host disease and treatment of auto-immune disorders. Additionally, the incidence of invasive fungal infections is increasing with the use of new antineoplastic therapies for malignancy, increasing incidence of diabetes mellitus, expanded use of broad-spectrum antimicrobial therapy and with an aging population with chronic medical problems such as chronic renal failure, chronic obstructive pulmonary disease and HIV. We present a case of primary cutaneous zygomycosis at the insertion site of a central venous catheter in a 45-year-old renal transplant patient admitted for acute pancreatitis. In the critical care setting, clinicians must retain a high index of suspicion for invasive fungal infections in immunocompromised individuals to ensure early diagnosis and provide aggressive medical and surgical intervention. Liposomal amphoterin B is the first line antimicrobial therapy, and reduction or discontinuation of immunosuppressive therapy should be considered. Currently there are no consensus opinions or recommendations for routine, scheduled replacement of central venous catheters to prevent infections, even in immunosuppressed patients.

AB - Invasive fungal infections are increasing in incidence, along with the use of immunosuppressive medications for the prevention of organ transplant rejection, graft versus host disease and treatment of auto-immune disorders. Additionally, the incidence of invasive fungal infections is increasing with the use of new antineoplastic therapies for malignancy, increasing incidence of diabetes mellitus, expanded use of broad-spectrum antimicrobial therapy and with an aging population with chronic medical problems such as chronic renal failure, chronic obstructive pulmonary disease and HIV. We present a case of primary cutaneous zygomycosis at the insertion site of a central venous catheter in a 45-year-old renal transplant patient admitted for acute pancreatitis. In the critical care setting, clinicians must retain a high index of suspicion for invasive fungal infections in immunocompromised individuals to ensure early diagnosis and provide aggressive medical and surgical intervention. Liposomal amphoterin B is the first line antimicrobial therapy, and reduction or discontinuation of immunosuppressive therapy should be considered. Currently there are no consensus opinions or recommendations for routine, scheduled replacement of central venous catheters to prevent infections, even in immunosuppressed patients.

UR - http://www.scopus.com/inward/record.url?scp=84865856661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865856661&partnerID=8YFLogxK

U2 - 10.1071/HI12011

DO - 10.1071/HI12011

M3 - Article

AN - SCOPUS:84865856661

VL - 17

SP - 83

EP - 86

JO - Infection, Disease and Health

JF - Infection, Disease and Health

SN - 2468-0451

IS - 3

ER -